Martingale Asset Management’s Twist Bioscience TWST Stock Holding History

Martingale Asset Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-15,989	Closed	-$549K	–	854
2024 Q1	$549K	Sell	15,989 -1,705	-10%	-$61.5K	0.01%	601
2023 Q4	$652K	Sell	17,694 -4,641	-21%	-$107K	0.01%	549
2023 Q3	$453K	Sell	22,335 -2,598	-10%	-$57.1K	0.01%	625
2023 Q2	$510K	Buy	24,933 +10,002	+67%	+$150K	0.01%	607
2023 Q1	$225K	Buy	+14,931	New	+$330K	﹤0.01%	758
2021 Q1	–	Sell	-3,809	Closed	-$539K	–	921
2020 Q4	$539K	Sell	3,809 -36,002	-90%	-$3.99M	0.01%	594
2020 Q3	$3.02M	Sell	39,811 -52,196	-57%	-$3.25M	0.04%	322
2020 Q2	$4.17M	Buy	92,007 +47,507	+107%	+$1.7M	0.05%	348
2020 Q1	$1.36M	Buy	+44,500	New	+$1.2M	0.02%	589

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Martingale Asset Management's TWST Position: Q2 2024 in Review

Martingale Asset Management sold out of Twist Bioscience (TWST) in Q2 2024, closing a stake of 15,989 shares — an estimated $549K sold.

Martingale Asset Management first reported a position in TWST in Q1 2020 and held it in 9 quarters. The position peaked at $4.17M in Q2 2020. 262 funds tracked by Wall St. Rank hold TWST as of Q2 2024.

Martingale Asset Management reported no remaining Twist Bioscience position as of Q2 2024 after selling out during the quarter.
Martingale Asset Management sold 15,989 Twist Bioscience shares in Q2 2024, an estimated $549K.
Martingale Asset Management first reported a position in Twist Bioscience in Q1 2020 and held it in 9 quarters.
Martingale Asset Management's Twist Bioscience position peaked at $4.17M in Q2 2020.
262 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2024.

Based on Martingale Asset Management's 13F filing for Q2 2024, filed 12 Aug 2024.